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Abstract
Protein kinase C (PKC) is activated by lipid second messengers or redox action, raising the question whether
these activation modes involve the same or alternate mechanisms. Here we show that both lipid activators and
oxidation target the zinc-finger domains of PKC, suggesting a unifying activation mechanism. We found that
lipid agonist-binding or redox action leads to zinc release and disassembly of zinc fingers, thus triggering large-
scale unfolding that underlies conversion to the active enzyme. These results suggest that PKC zinc fingers,
originally considered purely structural devices, are in fact redox-sensitive flexible hinges, whose conformation is
controlled both by redox conditions and lipid agonists. Antioxid. Redox Signal. 14, 757–766.
Introduction
Historically, the term ‘‘zinc-finger’’ refers to zinc-coordinated protein modules associated with mamma-
lian transcription factors. The defining features are sets of two
cysteines and two histidines, each recruited from different
parts of a single polypeptide chain and arranged at their core
into a tetrahedron. The extraordinarily high binding affinity
of zinc chelated by these four ligands endows such protein
folds with a high degree of rigidity, allowing protruding
peptide loops of variable composition to intercalate finger-like
fashion into DNA—hence the name (4, 27).
Far from restricted to transcription factors, zinc fingers
occur in diverse classes of other pro- and eukaryotic proteins,
including chaperones, kinases, ligases, or DNA processing
enzymes (5, 9, 19, 32). While the basic principle of a zinc co-
ordinated, rigid peptide core is maintained, diverse tetra-
hedral configurations have evolved that employ varied
combinations of cysteine and histidine residues (26). These
include the intricate structures found in serine=threonine ki-
nases and other signaling molecules that contain complex
arrangements of dual zinc-coordination centers, resembling
butterflies (37). Further, tandem arrangements of two, three,
or up to nine zinc fingers are not infrequent, but the utility of
such concatenations is not fully understood.
The zinc fingers of serine=threonine kinases, such as pro-
tein kinase C (PKC), have no relevance for DNA binding but
are thought to arrange proteins into specific tertiary confor-
mations, not unlike disulfide bonds in extracellular proteins.
However, zinc fingers depend on reducing conditions prev-
alent in the cytosol. They theoretically share with disulfide
bonds the capacity for redox-mediated conformation change,
although themechanism of their disassembly is different from
that of disulfide bridges (36). While the latter depend on re-
duction, the ionic nature of zinc coordination requires oxi-
dation of critical cysteine residues. Because loss of key thiolate
anions compromises the high-affinity chelate bond, condi-
tions conducive to conformation change theoretically exist.
Indeed one of us (U.J.) demonstrated this paradigm in the
bacterial chaperone, heat-shock protein-33 (Hsp33) (19). This
protein contains a zinc finger, composed of four highly con-
served cysteines chelated by a single zinc ion, which stabilizes
the inactive chaperone and acts as a redox sensor. Under
conditions of oxidative stress, two intramolecular disulfide
bonds form, causing zinc release and dramatic conforma-
tional rearrangements, leading to the full chaperone activity
(11, 16).
Eleven PKC isoforms and three Raf kinases share with
Hsp33 both the zinc fingers in their regulatory domains and
the ability to respond to oxidative stress (22, 31). The non-
classical activation mechanism of these enzymes by redox
chemistry, requiring neither lipid second messengers nor ac-
tivated ras, is obscure, both with respect to the nature of ox-
idizing agents and the covalent modification effected.
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However, escape from autoinhibition and conversion to the
active form requires large-scale unfolding (15), reminiscent of
the redox-mediated activation of Hsp33. Loss of zinc coordi-
nation in response to redox action or phorbol ester stimulation
was inferred from findings that activated PKCs shed signifi-
cant amounts of zinc ions (21, 24), providing a first indication
that the two activation mechanisms potentially share some
common features. Progress was, however, hampered by the
large size of PKC and inadequacies of contemporary physi-
cochemical methods to study their internal dynamics.
In the present model study we furnish support for the hy-
pothesis that mammalian zinc fingers are operational ortho-
logs of bacterial ones. Completely different from Hsp33 in
peptide configuration and butterfly-like architecture, PKC
zinc centers, nonetheless, function as redox-sensitive, flexible
hinges. Under oxidative stress conditions, PKC zinc fingers
shed zinc and disassemble. We demonstrate that PKC-
activating lipid second messengers, including phosphatidyl-
serine (PS), diacyl glycerol (DAG), and its pharmacomimetics,
phorbol esters, act likewise by dissociating PKC zinc centers,
and that in full-length PKC zinc release correlates with ac-
quisition of enzymatic competence. By substituting the PKC
zinc finger for its bacterial ortholog, we created chimeric
Hsp33 reporter proteins that retain full responsiveness to
oxidation and acquire responsiveness to cognate lipid second
messengers. On the basis of collective findings, we propose
that PKC zinc fingers, contrary to earlier beliefs, are not static,
redox-inert, and rigid folds but constitute flexible elements
that on cue undergo biologically relevant conformational re-
arrangements, necessary for the activation of PKC.
Results and Discussion
Zinc-finger domains shed zinc in response to oxidation
or phorbol binding
The defining feature of zinc fingers is the tetrahedral ar-
chitecture of Zn2þ ions centered within four equidistant neg-
atively charged cysteine=histidine combinations. The ionic
field effect of extraordinary strength stabilizes the tertiary
conformation of cytosolic proteins. Because the zinc-finger
fold depends on the coordination of zinc by cysteine-thiolate
anions, oxidizing conditions are expected to release Zn2þ
ions from high-affinity chelation. We verified this prediction
using the colorimetric zinc-release assay, based on the 4-(2-
pyridylazo)-resorcinol (PAR) indicator dye (10). The PKCa
C1b zinc-finger domain was expressed as a fusion protein
(designated maltose-binding protein [MBP]-PKCaC1b). The
purified recombinant protein, containing two zinc equiva-
lents, was subjected to peroxide-mediated oxidation. Incuba-
tion with <1mM hydrogen peroxide produced the release of
100% of Zn2þ within 5min at 378C, relative to the total sulf-
hydryl-bound Zn2þ displaced by p-mercurimethyl-phenyl-
sulfonate (PMPS), a potent sulfhydryl poison (14) (Fig. 1A).
The second messenger mimetic, phorbol-12-myristoyl-13-
acetate (PMA), was reported to cause PKCa to shed half its
zinc content in vivo (24). These findings raised the question
whether lipid-binding resulted in loss of zinc coordination.
The high-affinity binding site for lipid secondmessengers was
mapped to the second dC1b zinc center (37). We hypothesized
that long-chain fatty acids of agonists disturb the tetrahedral
symmetry on which zinc-finger integrity depends, collapsing
the ionic field effect. We tested this possibility with the zinc-
release assay, using the MBP-PKCaC1b fusion protein. In-
cubation with graded doses of PMA at 258C resulted in the
specific release of half the bound Zn2þ in vitro. Phorbol-13-
acetate (P13A), a PKC-agonist with much lower potency than
PMA but equally high binding affinity to PKC (37), did not
cause detectable Zn2þ release at similar conditions (Fig. 1B),
suggesting that the myristoyl chain was instrumental for zinc
release. We demonstrated selectivity of PMA by testing MBP-
PKCz fusion protein, not known to bind PMA (30), and did
not observe any zinc release (Fig. 1C). Oxidation of MBP-
PKCz with peroxide, however, yielded maximal zinc release
(data not shown).
FIG. 1. Zinc release by oxidation and lipid second messengers. (A) The zinc finger of maltose-binding protein (MBP)–
protein kinase C a (PKCa) C1b is redox sensitive. Purified MBP-PKCa C1b fusion protein was incubated with increasing
doses of H2O2 for 5min at 378C. Zinc release was monitored colorimetrically. Oxidation caused the release of two molar
equivalents of Zn2þ. PMPS is a reagent that forms thiol-mercaptide bonds with cysteines, thereby releasing all bound zinc
from cysteine-containing zinc centers. Incubation of the MBP-PKCa C1b fusion protein with PMPS resulted in the release of
two molar equivalents of Zn2þ, indicating that both zinc-coordination centers were intact in the starting material. (B) The zinc
finger of MBP-PKCa C1b responds to phorbol ester binding by releasing zinc. Purified MBP-PKCa C1b fusion protein was
incubated with increasing doses of phorbol-12-myristoyl-13-acetate (PMA) or phorbol-13-acetate (P13A) for 5min at 378C.
Zinc release was monitored colorimetrically. PMA caused the release of one zinc equivalent from MBP-PKCa C1b at max-
imum dose (200mg=ml), whereas the weak phorbol agonist, P13A, was ineffective at similar concentrations. (C) The zinc
finger of MBP-PKCz C1 does not respond to phorbol ester binding. Purified MBP-PKCz C1 fusion protein, containing a PMA
nonbinding zinc finger, was incubated with increasing doses of PMA for 5min at 378C. Zinc release was monitored color-
imetrically (titration not shown). The fusion protein failed to yield free Zn2þ upon stimulation with 200 mg=ml PMA. PMPS
released two zinc equivalents. (D) The zinc finger of MBP-PKCa C1b responds to di-acyl-glycerol (DAG) and phosphatidyl-
serine (PS) binding by releasing zinc. Both DAG and PS, applied with phosphocholine-based lipid vesicles, caused substantial
zinc release from MBP-PKCa C1b fusion protein. The combination of DAG and PS released one Zn2þ equivalent, comparable
to the molar ratio freed by PMA (as shown in B). (E) The zinc finger of full-length PKCa responds to phorbol ester binding by
releasing zinc. Purified full-length PKCa, expressed in insect cells, was incubated with increasing doses of PMA or P13A for
5min at 378C. Zinc release was monitored colorimetrically. PKCa responded to stimulation with PMA, but not P13A, and
released at 200mg=ml PMA two of its four zinc equivalents. Vehicle control was negative. (F) Full-length PKCa was activated
by phorbol ester. Purified full-length PKCa, expressed in insect cells, was incubated with 200 mg=ml PMA or P13A for 5min
at 378C. Kinase activity was determined by measuring phosphotransferase capacity with histone as substrate. Upon stim-
ulation with PMA full-length PKCa gained 22-fold higher phosphotransferase activity, whereas P13A produced less than half
of this activity ( p> 0.001). (For interpretation of the references to color in this figure legend, the reader is referred to the web
version of this article at www.liebertonline.com=ars).
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PMA functions as pharmacomimetic, raising the question
whether the natural second messengers, DAG and PS, also
destabilized PKC zinc fingers (35). Being insoluble in water,
both agonists were delivered with phosphatidylcholine
(PC)-based lipid vesicles (34), and both caused significant
zinc release from MBP-aC1b fusion protein, although to a
lesser degree than PMA (Fig. 1D). Applied in combination,
their effect was additive and commensurate with that eli-
cited by PMA. Neither PC itself nor saturated fatty acids
incorporated into PC produced zinc release (data not
shown).
In their natural settings, zinc fingers might be stabilized by
adjacent peptide domains. It was therefore important to test
the responsiveness of intact PKC to lipid second messengers.
Oxidation of PKC by hydrogen peroxide in vitro inactivates
the enzyme (10) presumably because of nonpermissible
modifications of cysteines in the catalytic domain and else-
where. Therefore, zinc-release tests would not be informative.
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However, when purified, full-length aPKC (7) was treated
with PMA at 258C, it converted to an active enzyme, as
demonstrated by phosphotransfer to histone substrate, and
simultaneously released two of its four zinc equivalents (Fig.
1E, F). Densitometric analysis of the histone autoradiograph
indicated that PMA produced a 20-fold increase in phos-
photransferase activity. P13A caused less than half of the
PKCa activation achieved with PMA, and again, like in the
MBP-fusion protein, no measurable zinc release (Fig. 1E, F).
Together, these results indicate that potent agonists of PKC
possess the ability to displace Zn2þ from the PKCa zinc-finger
domain in vitro, whether expressed as fusion protein or con-
tained in its natural state within the full-length molecule. The
results support a mechanismwhereby disassembly of the zinc
center is associated with the conversion of PKC from the in-
active to the active enzyme, in accord with the notion that
PKC activation depends on large-scale protein unfolding (15).
The effective dose of P13A is lower by an order of magnitude
than that of PMA, and consistent with this the activation of
PKCawas attenuated. It is unclear why no Zn2þwas released
or why the PAR assay failed to detect this.
The PKC zinc finger is a functional ortholog
of the bacterial Hsp33 zinc finger
During in vivo activation, PKC undergoes a number of
requisite phosphorylation events (20, 30, 33), including au-
tophosphorylation, and translocates to diverse membrane
sites (25). This complex process makes it difficult to assess to
what extent the unfolding of the zinc-finger domain per se
contributes to the activation process. To circumvent these
potentially confounding factors, we constructed a reporter
protein that allowed evaluation of the zinc-finger function
unencumbered by other PKC domains. The bacterial Hsp33
chaperone is structurally completely unrelated, yet shares
the prototypical, redox-sensitive zinc-finger structure with
PKC (19). If the sole function of the Hsp33 zinc finger were to
open on cue, enabling the protein to undergo the required
rearrangements and dimerization, we reasoned that it
should be possible to substitute the PKC zinc finger for the
endogenous one without loss of redox sensitivity. Chimeric
Hsp33=PKC C1b proteins were constructed, expressed in
bacteria, and purified to homogeneity. A content of 2 mo-
lar Zn2þ equivalents indicated proper folding of zinc-
coordination centers (Fig. 2A). To evaluate whether the
functionality of the PKC zinc-finger domain was compromised
by insertion into Hsp33, we applied the zinc release assays
(14). We found that oxidation of the chimeric protein with
H2O2 released 100% of its high-affinity bound Zn
2þ (data not
shown). Stimulation by PMA caused specific, half-maximal
zinc release from the chimeric Hsp33=PKCa and Hsp33=
PKCe proteins (Fig. 2A), comparable to the results of zinc
release of recombinant MBP-PKCa C1b protein and full-
length PKCa. The weak agonist, P13A, failed again to gener-
ate appreciable free Zn2þ (Fig. 2A). To guard against the
possibility that reactive oxygen species (ROS) were generated
during PMA stimulation, assays were performed in the
presence of 5mM b-mercapto-ethanol. Although it neutral-
ized H2O2-mediated zinc release (data not shown), this re-
ducing agent did not interfere with PMA freeing Zn2þ (Fig.
2A). These results demonstrate that the PKC zinc fingers re-
tain their integrity despite their incorporation into the Hsp33
protein, but they do not tell us whether they retain their
functionality as activation centers.
The purpose of the Hsp33 chaperone is to protect proteins
against nonspecific aggregation specifically under oxidative
stress conditions (16). Activation of Hsp33 requires oxidative
zinc release from the zinc center, whose unfolding destabilizes
an adjacent linker region, which, in turn, unfolds and exposes
a hydrophobic surface, suggested to represent the high-
affinity binding site for misfolded protein substrates (16). We
evaluated the chaperone activity of the Hsp33 chimera by a
light scattering assay based on the ability of activated Hsp33
to prevent the aggregation of chemically unfolded citrate
synthase (CS) (6). Under reducing conditions, wild-type
Hsp33 is unable to prevent the aggregation of denatured CS
(Fig. 2B, compare black and blue trace). However, H2O2
(or HOCl)-activated Hsp33 prevents the aggregation of CS
(Fig. 2B, red trace). Likewise, we found that the chimeric
PKC=Hsp33 proteins (Fig. 2C, D) were inactive under re-
ducing conditions, but responded to redox activation like the
wild-type form (see also Fig. 2E). These results demonstrate
that PKC’s butterfly zinc finger serves as a redox-sensitive,
autonomous folding unit, which can readily substitute for
Hsp33’s zinc finger.
If zinc-finger disassembly were the key initiator of linker
region destabilization and large-scale Hsp33 remodeling (12),
we would also expect PMA to accomplish chaperone activa-
tion. Indeed PMA efficiently activated the chimeric chaper-
ones but not native Hsp33, yielding a threefold increase over
background (Fig. 2E). The weak agonist P13A produced only
marginal chaperone activation. In summary, our results show
that the bacterial and mammalian zinc-finger modules are
interchangeable. Considering that zinc is released during
PMA activation without oxidation of the cysteines (Fig. 2A),
our results strongly imply that the disassembly of the zinc-
coordination centers is an early step in a cascade of events
leading to and possibly preceding full activation of the
chaperone. Neither the origin of the zinc-finger module nor
the mode of triggering, whether by oxidation or by physical
means, appears to change this outcome.
The PKC zinc finger changes its conformation
upon lipid agonist binding
As zinc release and conversion to active chaperone im-
plied extensive structural reorganization, we searched for
direct evidence for disassembly of the zinc-finger fold. To
observe conformation changes by nuclear magnetic reso-
nance (NMR), we expressed 15N-enriched recombinant
protein and recorded HSQC spectra before and after expo-
sure to PMA. The 15N-1H HSQC spectrum of the uniformly
15N-labeled PKCa C1b revealed a well-structured domain in
solution, identical with that of the published NMR structure
(Fig. 3A) (12). Exposure to PMA produced a conformer that
lacked dispersion, indicating loss of tertiary structure (Fig.
3B). Changes in some peak positions upon P13A exposure
indicated that this lipid bound PKCa C1b, without causing
loss of structure (Fig. 3C). Exposure to vehicle alone (di-
methyl sulfoxide [DMSO]) did not change the HSQC spec-
trum (Fig. 3D).
To evaluate the effect of PMA on the chimeric Hsp33=PKCe
C1b protein, we used 15N-cysteine labeling that allowed se-
lectivemonitoring of zinc coordinationwhile greatly reducing
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FIG. 2. Chaperone activity of heat-shock protein-33 (Hsp33)-PKC chimeras is regulated by oxidation and by second mes-
sengers. (A) The Hsp33=eC1b reporter protein responds to PMA by half-maximal zinc release. Purified Hsp33=eC1b protein was
titratedwith PMAor P13A under the conditions described in (B). This resulted at maximumPMA concentration (200mg=ml) in the
release of twomolar equivalents. PMPS yielded the expected four zinc equivalents. The PMA effect was not mediated by oxidation
since the presence of b-mercaptoethanol did not diminish PMA effectiveness. P13A did not cause zinc release. Chaperone activity
of native Escherichia coli Hsp33 (B), the chimeric Hsp33=aC1b protein (C), or the chimeric Hsp33eC1b mutant protein (D). The
influence of these proteins on the aggregation of chemically denatured citrate synthase (CS) at 308Cwas tested. Light scattering of
CS in the absence of any chaperones (black traces), in the presence of reduced, inactive chaperones (blue traces), or in the presence of
oxidized chaperones, which were treated with 2mM H2O2 at 438C for 3h (red traces), was monitored. (E) Effect of second
messengers on the chaperone activity of Hsp33 and the chimeric Hsp33eC1bmutant protein. The reduced proteins were incubated
in PMA, P13A, or HOCl for 3h at 308C. Then, the proteins were diluted 1:166-fold into the assay buffer and their effects on the
aggregation of chemically denatured CSwas determined as described. The residual concentrations of PMA, P13A or HOCl present
in the assay buffer, did not have any significant effect on the light scattering signal of CS alone. Presence of PKCe C1b zinc finger
conferred responsiveness to PMA at 308C, but not to P13A. Native Hsp33 was not responsive to PMA. Both native and chimeric
Hsp33 proteins were activated by hypochlorite (HOCl). Results presented are representative of at least three repeat experiments.
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spectral complexity. Because activated Hsp33 naturally is a
homodimer, we eliminated the critical dimerization site E150
via mutation to arginine (11), thus minimizing interpretation
errors arising from self-association of proteins. Like our ob-
servations with the PKCa C1b domain, exposure to PMA
caused unraveling of the zinc-coordination site in the chimeric
Hsp33 PKCe C1b protein (compare Fig. 3E with 3F), whereas
exposure to P13A (Fig. 3G), or vehicle alone (not shown), did
not cause significant changes in the HSQC spectra. Thus, our
results indicate that interaction with PMA or with the natural
activator of PKC, DAG, leads to the loss of tertiary structure in
the zinc-finger motif of the PKC C1b domain.
Redox activation of PKCd in mitochondria involves
targeted oxidation of its zinc finger by cytochrome c
The observations that lipid second messengers and oxida-
tion impinged on the zinc-finger domain and caused their
disassembly underscored the importance of the hinge-like
function for PKC activation. It is structurally and functionally
well established that zinc fingers represent the activation
domains where DAG and phorbol-ester bind (31). However,
are these same zinc fingers the key targets for redox activation
as well? If so, what is the source of oxidizing agents, andwhat
is the molecular mechanism? It is often assumed that ROS are
responsible for oxidation, but ROS lack the ability for site-
specific reactions, any cysteine residue in PKC potentially
offering a target. However, for the same reasons that kinases
and phosphatases perform site-specific, ‘‘hand-shake’’-like
transactions (28) we postulated oxidation by an oxido-re-
ductase, instead of free ROS. We recently described the first
example of such site-specific redox activation of PKCd in
mitochondria (1). Cytochrome c was the oxidizing agent, but
was only effective when vitamin Awas present. This essential
coactivator was long known to bind tightly to PKC zinc fin-
gers, although the purpose of this association was unclear (13,
18). To test the hypothesis that redox activation involves
electron transfer from the zinc finger to cytochrome c, a pro-
cess in which vitamin A functions as electron carrier, we ge-
netically ablated the retinol-binding pockets on PKCd (2). The
mutated PKCd was no longer activated by oxidized cyto-
chrome c (Fig. 4). Besides illuminating a new role of vitamin A
in signal transduction, in the context of the present study the
results strongly implicate the zinc-finger domains as the me-
diators of redox activation. In view of definitive structural
changes observed in NMR experiments and others deduced
from zinc-release studies, we propose that the dynamics of
zinc fingers are important for the regulation of PKC activity.
Concluding Remarks and Outlook
Zinc-finger domains occur in hundreds of mammalian
proteins, many of these conserved from distant evolutionary
time. The question arises whether interconversion of well-
ordered rigid zinc-finger domains to unstructured folds by
redoxmechanisms or, as nowdemonstratedwith our reporter
protein, by specific lipid binding, is more common than
hitherto appreciated. Transcription factors bind DNA by de-
ploying zinc fingers; do they not eventually need to come off
their promoters? Ring fingers are thought to mediate protein–
protein recognition; does this process not require regulation
by alternately presenting and concealing recognition faces?
Topoisomerases ratchet hand-over-hand along DNA using
strings of zinc fingers; does this not imply cyclical opening
and closing of zinc fingers? Future work will tell how many
more zinc fingers serve as dynamic elements, and what ad-
ditional means beyond redox mechanisms and lipid interac-
tions exist to trigger conformation change of these domains.
Experimental Procedures
Chemicals and biological reagents
PAR, PMA, and P13A were purchased from Sigma (St.
Louis, MO). PC and PS were from Avanti Polar Lipids (Ala-
baster, AL). PMPSwas synthesized according toNesmejanow
(29).
Plasmids and recombinant proteins
A vector encoding the C1b domain of rat PKCa
(HKFKIHTYGSPTTFCDHCGSLLYGLIHQGMKCDTCDMNV
HKQCVINVPSLC) fused to MBP was kindly provided by U.
Hommel (12). The PKCe C1b domain was fused to MBP in
analogous fashion. The proteins were expressed in Escherichia
coli and purified by affinity chromatography on maltose aga-
rose according to the manufacturer’s instructions (New Eng-
land Biosciences, Beverley, MA). The purity, as determined by
sodium dodecyl sulfate–polyacrylamide gel electrophoresis,
exceeded 95%. The proteins contained two equivalents of Zn2þ
(see below), indicating complete folding. The NMR HSQC
spectrum of the cleaved aC1b domain matched published data
(12). The fusion proteins were stored with reducing agent at
48C.Hsp33 proteinwas purified as described (19). The chimeric
chaperones were generated by excising the endogenous zinc
finger (residues 232–268, retaining the C-terminal cysteine) and
inserting the murine PKC aC1b domain (residues as above,
preceded by the linker amino acids, MNP) or the PKCe C1b
FIG. 3. Zinc release and chaperone activation are associated with structural changes in the zinc-finger fold. (A-D) The
zinc-finger folds of PKCa C1b loose their structure upon exposure to phorbol ester. (A) The HSQC spectrum of [U-15N]
PKCaC1b (250 mM) shows a well-structured fold comparable to that of published spectra [14]. (B) After stimulation with PMA
(protein:PMA ratio¼ 1:2.6), some precipitation occurred. However, after removal of aggregates the spectrum of the super-
natant showed a disordered structure. (C) Treatment with P13A (1:2.6 molar ratio) caused only minor shifts. (D) Treatment
with vehicle (dimethyl sulfoxide) caused no discernible shifts. (E) The chimeric Hsp33=eC1b protein was uniformly labeled
with [15N]L-cysteine. The HSQC spectrum of the untreated protein (100mM) revealed signals from six cysteine residues, and
additional lower intensity signals arising from scrambling of the 15N label. (F) PMA treatment (protein:PMA, 1:1.3) resulted in
some precipitation, as in (B). The HSQC spectrum of the supernatant (*80mM) showed broadening of signals suggesting loss
of structure. (G) The weak phorbol agonist, P13A, while eliciting shifts of some cysteine residues (shown at 1:2.6 molar ratio),
possibly due to secondary rearrangement in Hsp33, retained the six core cysteines in the fixed positions, indicating a
structurally intact zinc finger.
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domain (KFGIHNYKVPTFCDHCGSLLWGLLRQGLQCKVC
KMNVHRRCETNVAPNC), preceded by the linker amino ac-
ids, NMPC. The proteins were purified from E. coli lysates by
ion exchange chromatography on MonoQ agarose, yielding
95%purity and two zinc equivalents, indicating proper folding.
Zinc-release assay
Test proteins were purged of reducing agent by gel filtra-
tion and diluted to 5 mM in 50 mM Tris=HCl buffer (pH 7.5)
(14). PAR was added at a final concentration of 100mM. To
determine the content of chelated Zn2þ, p-mercurimethyl-
phenyl-sulfonate (PMPS) was added in small increments until
saturation was achieved. The PAR-Zn2þ complex was mea-
sured colorimetrically at lmax 500 nm. A Zn
2þ standard curve
was used to convert OD units to molarity. Data are presented
as molar ratios of Zn2þ to protein.
One hundred twenty microliters of test protein (5mM) with
indicator dye was titrated at room temperature with hydro-
gen peroxide in water, phorbol-12-myristoyl-13-acetate
(PMA), or P13A, both dissolved in DMSO. When saturation
was reached, PMPS was added to release residual high-
affinity boundZn2þ. All titrationswere performed in triplicates.
Means and standard deviations of the mean were calculated
using the Student’s t-test. Because DAG and PS are insoluble
in water, they were supplied as lipid vesicles generated with
PC as base, as described by Sando (34). Note that because of
their lipid nature the amounts used are given in mg=ml. They
correspond to apparent concentrations, not actual molarities.
Measurements of chaperone activity
Purified native Hsp33 and the chimeras were reduced and
zinc reconstituted as described (6). About 50mM of the re-
duced proteins was incubated with 2mMH2O2, 15ml DMSO,
240 mM PMA, or 240 mM P13A (both dissolved in DMSO) for
one or 3 h at 308C. To determine the activity of the proteins,
aliquots were removed and the influence of 0.3 mM Hsp33 or
the chimera on the aggregation of 0.075mM chemically un-
folded CS (Sigma) was analyzed at 308C as described (17).
NMR spectroscopy
Uniformly 15N-labeled proteins were expressed in E. coli
using M9 medium with 15NH4Cl as the sole nitrogen source.
Selectively15N-cysteine labeled proteins were expressed in
Luria broth medium supplemented with 0.1g=l 15N-cysteine
according to the method of Englander et al. (8). For NMR
experiments, PKCa C1b was expressed as a fusion protein
with a N-terminal his-MBP tag (3) and cleaved from the af-
finity tag using thrombin. NMR experiments were performed
at 0.8mM and 0.1mM concentrations of PKCa C1b and
Hsp33=PKCe C1b, respectively, in 50mM Tris (pH 7.5) buffer
containing 100mM NaCl, 10mM b-mercaptoethanol, and
20mM ZnSO4 at 258C. All experiments were performed on
Bruker 700 or 800MHz spectrometers equipped with cryo-
probes.
For titrations, stock solutions of both PMA and P13A were
made in DMSO at a concentration of 10mg=ml. These were
added to protein samples in 1 ml increments with mixing at
each step.
Mitoplast preparation for cytochrome c import
Mitoplast for cytochrome c import were prepared from
embryonal fibroblasts (MEFs) cells that were cultured for 18h
in serum-free transferrin, linoleic acid, bovine serum albumin
medium (1). Mitochondria were isolated by homogenization
of the cell pellets in buffer A (0.32M sucrose, 1mM EDTA, and
10mM Tris-HCl, pH 7.4) followed by centrifugation at 1000g
for 5min. Supernatant containing mitochondria was then
centrifuged at 20,000g for 10min, and mitochondria were re-
suspended at 1mg=ml in MAITE buffer (10mM Tris-HCl, pH
7.4; 25mM sucrose; 75mM sorbitol; 100mM KCl; 10mM
K2HPO4; 0.05mM EDTA; 5mM MgCl2; 1mg=ml BSA). Digi-
tonin (1mg digitonin=5mg mitochondrial protein) was ad-
ded, and the mixture incubated on ice for 45min. Then, the
combination of 20mM cytochrome c plus 2 mM retinol was
added and the mitoplasts were incubated at 378C for 10min.
Pyruvateþmalate-driven respiration was measured to assure
functionality (data not shown) using 50 mg of the mitoplast
preparation, as described (1).
Immunoblot analysis
To determine the phosphorylation levels of PKCd in mito-
plast, 50mg of protein was separated by 12.5% sodium dodecyl
sulfate–polyacrylamide gel electrophoresis, electroblotted onto
FIG. 4. Redox activation of PKCd by cytochrome c in
mitochondria implicates the zinc-finger domain. Embry-
onal fibroblasts (MEF) of wild-type mice or mice with
germline deletion of the PKCd gene were used. The latter
were reconstituted with an engineered mutant form of PKCd
that does not bind vitamin A (retinol, Rol) in its zinc-finger
domains (PKCd=Rol=MEFs), and as the result of this defect
has lost the ability to become redox activated by cytochrome
c3þ in mitochondria (1,2). Mitoplasts of the WT and
PKCd=Rol-=- MEFs, prepared as described in Experimental
Procedures section, were incubated with 20mM oxidized
horse heart cytochrome c plus 2 mM retinol for 10min. Mi-
toplasts were analyzed by Western blot for the presence of
PKCd protein and the activated species of PKCd using a
phospho-Thr505-specific antibody as indicator (23). TIM23
was used as loading control. While PKCd of WT genotype
showed increased phosphorylation, the vitamin A-nonbinding
mutant form remained unphosphorylated. Both responded
to PMA by undergoing phosphorylation, indicating func-
tional integrity, despite ablation of the vitamin A-binding
site in the mutant form. These results illuminate the im-
portance of PKC zinc-finger domains as targets of redox
activation. A detailed analysis of activation of PKCd in mi-
tochondria was recently published (1).
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polyvinylidene fluoride filters (BioRad, Hercules, CA) and im-
munoblotted with the appropriate antibodies.
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Abbreviations Used
CS¼ citrate synthase
DAG¼diacyl glycerol
DMSO¼dimethyl sulfoxide
Hsp33¼heat-shock protein-33
MBP¼maltose-binding protein
NMR¼nuclear magnetic resonance
P13A¼phorbol-13-diacetate
PAR¼ 4-(2-pyridylazo)-resorcinol
PC¼phosphatidyl choline
PKC¼protein kinase C
PMA¼phorbol-12-myristoyl-13-acetate
PMPS¼p-mercurimethyl-phenyl-sulfonate
PS¼phosphatidyl-serine
ROS¼ reactive oxygen species
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